⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397826 | 0.64 | — | — | |
| SCHEMBL6845565 | 0.62 | — | — | |
| SCHEMBL12502146 | 0.61 | P2RX7 (0.40) | — | |
| SCHEMBL752148 | 0.59 | — | — | |
| SCHEMBL14458792 | 0.59 | — | — | |
| SCHEMBL1921548 | 0.56 | — | — | |
| SCHEMBL17398305 | 0.55 | — | — | |
| SCHEMBL646232 | 0.55 | — | — | |
| SCHEMBL1590471 | 0.55 | — | — | |
| SCHEMBL1589682 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018157046-A1 | METHODS OF TREATING SEIZURE DISORDERS | OVID THERAPEUTICS INC. (US) | 2018-08-30 | — | — | WO | claimed |
| EP-2723336-A1 | COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME | Centre National De La Recherche Scientifique (FR) | 2014-04-30 | — | — | EP | claimed |
| WO-2013001412-A1 | COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-03 | — | — | WO | claimed |
| EP-1330426-A4 | SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1330426-A1 | SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-30 | — | — | EP | claimed |
| WO-2002030868-A1 | SELECTIVE MAXI-K- POTASSIUM CHANNEL OPENERS FUNCTIONAL UNDER CONDITIONS OF HIGH INTRACELLULAR CALCIUM CONCENTRATION, METHODS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-04-18 | — | — | WO | claimed |
| WO-2018157046-A1 | METHODS OF TREATING SEIZURE DISORDERS | OVID THERAPEUTICS INC. (US) | 2018-08-30 | — | — | WO | disclosed |
| EP-2723336-A1 | COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME | Centre National De La Recherche Scientifique (FR) | 2014-04-30 | — | — | EP | disclosed |
| WO-2013001412-A1 | COMPOSITIONS FOR THE TREATMENT OF FRAGILE X SYNDROME | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-03 | — | — | WO | disclosed |